Sterling Accuris Achieves Over Rs 200 Cr in Revenue for FY25 and Records Positive EBITDA
Sterling Accuris Diagnostics managed 22% year-on-year growth, turning EBITDA positive in FY25.
Read moreDetailsSterling Accuris Diagnostics managed 22% year-on-year growth, turning EBITDA positive in FY25.
Read moreDetailsSterling Accuris Diagnostics achieved 22% growth in FY25, narrowing losses and turning EBITDA positive.
Read moreDetailsResearch-backed Indian startup journalism. Funding rounds, mergers and acquisitions, AI, and technology — every figure checked against primary sources.
© 2026 StartupSuperb. Research-backed Indian startup news: funding, AI, and technology.
© 2026 StartupSuperb. Research-backed Indian startup news: funding, AI, and technology.